The future outlook for Aurora Cannabis stock depends heavily on the continued growth of its high-margin international medical cannabis business—particularly in European markets like Germany—offsetting declines in domestic consumer recreational segments. Investors also monitor broader regulatory reform trajectories, cash conservation efforts, and sector-wide consolidation pressures that influence micro-cap and small-cap cannabis valuations.